News Release Details
Entegris Reports Results for Second Quarter Of 2022
-
Second-quarter revenue of
$692 million , increased 21% from prior year -
Second-quarter GAAP diluted EPS of
$0.73 , increased 12% -
Second-quarter non-GAAP diluted EPS of
$1.00 , increased 18%
Quarterly Financial Results Summary |
|||
(in thousands, except percentages and per share data) |
|||
GAAP Results |
|
|
|
Net sales |
|
|
|
Operating income |
|
|
|
Operating margin - as a % of net sales |
22.8% |
24.3% |
25.1% |
Net income |
|
|
|
Diluted earnings per common share |
|
|
|
Non-GAAP Results |
|||
Non-GAAP adjusted operating income |
|
|
|
Non-GAAP adjusted operating margin - as a % of net sales |
26.4% |
26.5% |
28.1% |
Non-GAAP net income |
|
|
|
Diluted non-GAAP earnings per common share |
|
|
|
Third-Quarter Outlook
For the third quarter ending
Segment Results
The Company reports its results in the following segments:
Specialty Chemicals and Engineered Materials (SCEM): SCEM provides high-performance and high-purity process chemistries, gases and materials, and safe and efficient delivery systems to support semiconductor and other advanced manufacturing processes.
Microcontamination Control (MC): MC offers solutions to filter and purify critical liquid chemistries and gases used in semiconductor manufacturing processes and other high-technology industries.
Advanced Materials Handling (AMH): AMH develops solutions to monitor, protect, transport and deliver critical liquid chemistries, wafers and other substrates for a broad set of applications in the semiconductor, life sciences and other high-technology industries.
Second-Quarter Results Conference Call Details
Entegris will hold a conference call to discuss its results for the second quarter on
Management’s slide presentation concerning the results for the second quarter will be posted on the Investor Relations section of www.entegris.com Tuesday morning before the call.
About Entegris
Entegris is the global leader in electronic materials for the semiconductor market. With approximately 8,800 employees across its global operations, Entegris offers the industry’s most comprehensive and innovative unit-driven end-to-end offering for semiconductor customers, in addition to solutions for the life sciences and other advanced manufacturing environments. Entegris’ solutions help customers improve their performance, productivity and yields to enable technologies that transform the world. It has manufacturing, customer service, and/or research facilities in
Non-GAAP Information
The Company’s condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in
Cautionary Note on Forward Looking Statements
This news release contains forward looking statements. The words “believe,” “expect,” “anticipate,” “intend,” “estimate,” “forecast,” “project,” “should,” “may,” “will,” “would” or the negative thereof and similar expressions are intended to identify such forward looking statements. These forward looking statements may include statements about the ongoing impacts of the COVID-19 pandemic and the conflict in
|
||||
Condensed Consolidated Statements of Operations |
||||
(In thousands, except per share data) |
||||
(Unaudited) |
||||
|
|
Three months ended |
||
|
|
|
|
|
Net sales |
|
|
|
|
Cost of sales |
382,092 |
305,968 |
339,826 |
|
|
Gross profit |
310,397 |
265,384 |
309,820 |
Selling, general and administrative expenses |
90,685 |
72,621 |
87,108 |
|
Engineering, research and development expenses |
49,248 |
41,972 |
46,715 |
|
Amortization of intangible assets |
12,494 |
11,902 |
12,651 |
|
|
Operating income |
157,970 |
138,889 |
163,346 |
Interest expense, net |
31,343 |
10,643 |
12,864 |
|
Other expense, net |
9,619 |
23,560 |
4,902 |
|
|
Income before income tax expense |
117,008 |
104,686 |
145,580 |
Income tax expense |
17,517 |
15,916 |
19,875 |
|
|
Net income |
|
|
|
|
|
|
|
|
|
|
|
||
Basic earnings per common share: |
|
|
|
|
Diluted earnings per common share: |
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding: |
|
|
|
|
|
Basic |
135,895 |
135,498 |
135,670 |
|
Diluted |
136,454 |
136,533 |
136,552 |
|
|||
Condensed Consolidated Statements of Operations |
|||
(In thousands, except per share data) |
|||
(Unaudited) |
|||
|
|
Six months ended |
|
|
|
|
|
Net sales |
|
|
|
Cost of sales |
721,918 |
583,826 |
|
|
Gross profit |
620,217 |
500,370 |
Selling, general and administrative expenses |
177,793 |
144,010 |
|
Engineering, research and development expenses |
95,963 |
79,720 |
|
Amortization of intangible assets |
25,145 |
23,773 |
|
|
Operating income |
321,316 |
252,867 |
Interest expense, net |
44,207 |
22,224 |
|
Other expense, net |
14,521 |
27,890 |
|
|
Income before income tax expense |
262,588 |
202,753 |
Income tax expense |
37,392 |
29,307 |
|
|
Net income |
|
|
|
|
|
|
|
|
||
Basic earnings per common share: |
|
|
|
Diluted earnings per common share: |
|
|
|
|
|
|
|
Weighted average shares outstanding: |
|
|
|
|
Basic |
135,783 |
135,283 |
|
Diluted |
136,503 |
136,518 |
|
|||||
Condensed Consolidated Balance Sheets |
|||||
(In thousands) |
|||||
(Unaudited) |
|||||
|
|
|
|
|
|
ASSETS |
|
|
|
|
|
Current assets: |
|
|
|
|
|
Cash, cash equivalents and restricted cash |
|
|
|||
Trade accounts and notes receivable, net |
381,251 |
347,413 |
|||
Inventories, net |
|
583,766 |
475,213 |
||
Deferred tax charges and refundable income taxes |
38,907 |
35,312 |
|||
Other current assets |
129,003 |
52,867 |
|||
Total current assets |
3,876,158 |
1,313,370 |
|||
Property, plant and equipment, net |
779,631 |
654,098 |
|||
Other assets: |
|
|
|
|
|
Right-of-use assets |
68,389 |
66,563 |
|||
|
789,540 |
793,702 |
|||
Intangible assets, net |
308,871 |
335,113 |
|||
Deferred tax assets and other noncurrent tax assets |
26,549 |
17,671 |
|||
Other |
|
12,033 |
11,379 |
||
Total assets |
|
|
|
||
LIABILITIES AND EQUITY |
|
||||
Current liabilities |
|
|
|
||
Accounts payable |
|
|
|
||
Accrued liabilities |
|
198,171 |
199,131 |
||
Income tax payable |
|
48,523 |
49,136 |
||
Total current liabilities |
393,135 |
379,001 |
|||
Long-term debt, excluding current maturities |
3,408,801 |
937,027 |
|||
Long-term lease liability |
|
60,893 |
60,101 |
||
Other liabilities |
|
85,628 |
101,986 |
||
Shareholders’ equity |
|
1,912,714 |
1,713,781 |
||
Total liabilities and equity |
|
|
|
||||
Condensed Consolidated Statements of Cash Flows |
||||
(In thousands) |
||||
(Unaudited) |
||||
|
Three months ended |
Six months ended |
||
|
|
|
|
|
Operating activities: |
|
|
|
|
Net income |
|
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
Depreciation |
24,381 |
22,574 |
48,286 |
44,669 |
Amortization |
12,494 |
11,902 |
25,145 |
23,773 |
Share-based compensation expense |
10,182 |
7,519 |
19,467 |
14,657 |
Loss on extinguishment of debt and modification |
— |
23,338 |
— |
23,338 |
Other |
8,492 |
(8,369) |
8,687 |
(203) |
Changes in operating assets and liabilities, net of effects of acquisitions: |
|
|
|
|
Trade accounts and notes receivable |
(26,138) |
(26,667) |
(57,309) |
(48,231) |
Inventories |
(47,465) |
(30,386) |
(124,941) |
(69,723) |
Accounts payable and accrued liabilities |
49,468 |
13,244 |
27,145 |
(15,347) |
Income taxes payable, refundable income taxes and noncurrent taxes payable |
(20,308) |
(22,854) |
(3,548) |
(26,442) |
Other |
313 |
2,784 |
6,570 |
15,033 |
Net cash provided by operating activities |
110,910 |
81,855 |
174,698 |
134,970 |
Investing activities: |
|
|
|
|
Acquisition of property and equipment |
(107,692) |
(41,771) |
(192,097) |
(85,101) |
Acquisition of business, net of cash acquired |
— |
(2,250) |
— |
(2,250) |
Other |
— |
18 |
1,123 |
90 |
Net cash used in investing activities |
(107,692) |
(44,003) |
(190,974) |
(87,261) |
Financing activities: |
|
|
|
|
Proceeds from revolving credit facility and long-term debt |
2,527,314 |
451,000 |
2,606,314 |
451,000 |
Payments of revolving credit facility and long-term debt |
(114,000) |
(601,000) |
(193,000) |
(601,000) |
Payments for debt extinguishment costs |
— |
(19,080) |
— |
(19,080) |
Payments for dividends |
(13,589) |
(10,889) |
(27,484) |
(21,797) |
Issuance of common stock |
5,598 |
15,245 |
8,977 |
16,817 |
Taxes paid related to net share settlement of equity awards |
(200) |
(55) |
(16,317) |
(15,093) |
Repurchase and retirement of common stock |
— |
(15,000) |
— |
(30,000) |
Other |
(10,204) |
(4,800) |
(11,166) |
(4,801) |
Net cash provided by (used in) financing activities |
2,394,919 |
(184,579) |
2,367,324 |
(223,954) |
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
(7,638) |
(760) |
(10,382) |
(3,615) |
Increase (decrease) in cash, cash equivalents and restricted cash |
2,390,499 |
(147,487) |
2,340,666 |
(179,860) |
Cash, cash equivalents and restricted cash at beginning of period |
352,732 |
548,520 |
402,565 |
580,893 |
Cash, cash equivalents and restricted cash at end of period |
|
|
|
|
|
||||||
Segment Information |
||||||
(In thousands) |
||||||
(Unaudited) |
||||||
|
Three months ended |
|
Six months ended |
|||
Net sales |
|
|
|
|
|
|
Specialty Chemicals and Engineered Materials |
|
|
|
|
|
|
Microcontamination Control |
274,133 |
227,521 |
266,637 |
|
540,770 |
434,620 |
Advanced Materials Handling |
224,084 |
172,502 |
198,113 |
|
422,197 |
321,043 |
Inter-segment elimination |
(13,457) |
(9,037) |
(11,525) |
|
(24,982) |
(18,374) |
Total net sales |
|
|
|
|
|
|
|
Three months ended |
|
Six months ended |
|||
Segment profit |
|
|
|
|
|
|
Specialty Chemicals and Engineered Materials |
|
|
|
|
|
|
Microcontamination Control |
100,107 |
78,132 |
98,618 |
|
198,725 |
148,698 |
Advanced Materials Handling |
46,926 |
42,093 |
46,690 |
|
93,616 |
74,188 |
Total segment profit |
192,751 |
165,170 |
194,159 |
|
386,910 |
302,387 |
Amortization of intangibles |
12,494 |
11,902 |
12,651 |
|
25,145 |
23,773 |
Unallocated expenses |
22,287 |
14,379 |
18,162 |
|
40,449 |
25,747 |
Total operating income |
|
|
|
|
|
|
|
||||||
Reconciliation of GAAP Gross Profit to Adjusted Gross Profit |
||||||
(In thousands) |
||||||
(Unaudited) |
||||||
|
Three months ended |
|
Six months ended |
|||
|
|
|
|
|
|
|
Net sales |
|
|
|
|
|
|
Gross profit-GAAP |
|
|
|
|
|
|
Adjusted gross profit |
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin - as a % of net sales |
44.8% |
46.4% |
47.7% |
|
46.2% |
46.2% |
Adjusted gross margin - as a % of net sales |
44.8% |
46.4% |
47.7% |
|
46.2% |
46.2% |
|
||||||
Reconciliation of GAAP Segment Profit to Adjusted Operating Income |
||||||
(In thousands) |
||||||
(Unaudited) |
||||||
|
Three months ended |
|
Six months ended |
|||
Segment profit-GAAP |
|
|
|
|
|
|
Specialty Chemicals and Engineered Materials (SCEM) |
|
|
|
|
|
|
Microcontamination Control (MC) |
100,107 |
78,132 |
98,618 |
|
198,725 |
148,698 |
Advanced Materials Handling (AMH) |
46,926 |
42,093 |
46,690 |
|
93,616 |
74,188 |
Total segment profit |
192,751 |
165,170 |
194,159 |
|
386,910 |
302,387 |
Amortization of intangible assets |
12,494 |
11,902 |
12,651 |
|
25,145 |
23,773 |
Unallocated expenses |
22,287 |
14,379 |
18,162 |
|
40,449 |
25,747 |
Total operating income |
|
|
|
|
|
|
|
Three months ended |
|
Six months ended |
|||
Adjusted segment profit |
|
|
|
|
|
|
SCEM segment profit |
|
|
|
|
|
|
Severance and restructuring costs |
— |
51 |
— |
|
— |
98 |
Charge for fair value write-up of acquired inventory sold |
— |
— |
— |
|
— |
— |
SCEM adjusted segment profit |
|
|
|
|
|
|
|
|
|
|
|
|
|
MC segment profit |
|
|
|
|
|
|
Severance and restructuring costs |
— |
55 |
— |
|
— |
106 |
MC adjusted segment profit |
|
|
|
|
|
|
|
|
|
|
|
|
|
AMH segment profit |
|
|
|
|
|
|
Severance and restructuring costs |
— |
38 |
— |
|
— |
75 |
AMH adjusted segment profit |
|
|
|
|
|
|
|
|
|
|
|
|
|
Unallocated general and administrative expenses |
|
|
|
|
|
|
Unallocated deal and integration costs |
(12,575) |
(632) |
(6,254) |
|
(18,829) |
(2,676) |
Unallocated severance and restructuring costs |
— |
(36) |
— |
|
— |
(44) |
Adjusted unallocated general and administrative expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total adjusted segment profit |
|
|
|
|
|
|
Adjusted amortization of intangible assets |
— |
— |
— |
|
— |
— |
Adjusted unallocated general and administrative expenses |
9,712 |
13,711 |
11,908 |
|
21,620 |
23,027 |
Total adjusted operating income |
|
|
|
|
|
|
|
||||||
Reconciliation of GAAP Net Income to Adjusted Operating Income and Adjusted EBITDA |
||||||
(In thousands) |
||||||
(Unaudited) |
||||||
|
Three months ended |
|
Six months ended |
|||
|
|
|
|
|
|
|
Net sales |
|
|
|
|
|
|
Net income |
|
|
|
|
|
|
Net income - as a % of net sales |
14.4% |
15.5% |
19.3% |
|
16.8% |
16.0% |
Adjustments to net income: |
|
|
|
|
|
|
Income tax expense |
17,517 |
15,916 |
19,875 |
|
37,392 |
29,307 |
Interest expense, net |
31,343 |
10,643 |
12,864 |
|
44,207 |
22,224 |
Other expense, net |
9,619 |
23,560 |
4,902 |
|
14,521 |
27,890 |
GAAP - Operating income |
157,970 |
138,889 |
163,346 |
|
321,316 |
252,867 |
Operating margin - as a % of net sales |
22.8% |
24.3% |
25.1% |
|
23.9% |
23.3% |
Deal and transaction costs |
2,410 |
— |
5,008 |
|
7,418 |
— |
Integration costs |
10,165 |
632 |
1,246 |
|
11,411 |
2,676 |
Severance and restructuring costs |
— |
180 |
— |
|
— |
323 |
Amortization of intangible assets |
12,494 |
11,902 |
12,651 |
|
25,145 |
23,773 |
Adjusted operating income |
183,039 |
151,603 |
182,251 |
|
365,290 |
279,639 |
Adjusted operating margin - as a % of net sales |
26.4% |
26.5% |
28.1% |
|
27.2% |
25.8% |
Depreciation |
24,381 |
22,574 |
23,905 |
|
48,286 |
44,669 |
Adjusted EBITDA |
|
|
|
|
|
|
Adjusted EBITDA - as a % of net sales |
30.0% |
30.5% |
31.7% |
|
30.8% |
29.9% |
|
||||||
Reconciliation of GAAP Net Income and Diluted Earnings per Common Share to Non-GAAP Net Income and Diluted Non-GAAP Earnings per Common Share |
||||||
(In thousands, except per share data) |
||||||
(Unaudited) |
||||||
|
Three months ended |
|
Six months ended |
|||
|
|
|
|
|
|
|
GAAP net income |
|
|
|
|
|
|
Adjustments to net income: |
|
|
|
|
|
|
Deal and transaction costs |
2,410 |
— |
5,008 |
|
7,418 |
— |
Integration costs |
10,165 |
632 |
1,246 |
|
11,411 |
2,676 |
Severance and restructuring costs |
— |
180 |
— |
|
— |
323 |
Loss on extinguishment of debt and modification |
— |
23,338 |
— |
|
— |
23,338 |
Interest expense, net |
22,742 |
— |
4,683 |
|
27,425 |
— |
Amortization of intangible assets |
12,494 |
11,902 |
12,651 |
|
25,145 |
23,773 |
Tax effect of adjustments to net income and discrete items1 |
(10,486) |
(8,111) |
(4,160) |
|
(14,646) |
(11,332) |
Non-GAAP net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per common share |
|
|
|
|
|
|
Effect of adjustments to net income |
|
|
|
|
|
|
Diluted non-GAAP earnings per common share |
|
|
|
|
|
|
1The tax effect of pre-tax adjustments to net income was calculated using the applicable marginal tax rate during the respective years. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220802005275/en/
VP of Investor Relations
T + 1 952 556 1844
bill.seymour@entegris.com
Source: